MedTrace Logo

Designing Biofunctional Dairy Foods: Matrix Structure of Dairy Products in Relation to Lipaemia

NCT03656367 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2021-11-01

No results posted yet for this study

Summary

The overall aim of this study is to investigate how dairy products with different structures and textures affect lipid absorption kinetics in the acute postprandial period via blood lipid biochemistry.

The study will be conducted as a randomized acute cross-over meal study. Apparently healthy men will be recruited in the study. They will on 4 test days consume the 4 dairy products and blood will be drawn the following 8 hours.

Conditions

  • Lipaemia

Interventions

DIETARY_SUPPLEMENT

Cheddar cheese

The reference product is a commercial matured cheddar cheese

DIETARY_SUPPLEMENT

Blended and homogenized cheddar cheese

A blended and homogenized cheddar cheese (a spread) which, compared to the reference, has a minimal protein network and has smaller fat droplet

DIETARY_SUPPLEMENT

An analog milk

An anolog milk (i.e. milk with a cheese-like nutritional composition) which, compared to the reference, does not contain a protein network

DIETARY_SUPPLEMENT

An analog cheese

This analog cheese (a gel/yoghurt) is produced from the analog milk which, compared to the reference, has a protein network, however it is a network that differs from the reference

Sponsors & Collaborators

  • University of Aarhus

    collaborator OTHER

  • Arla Foods

    collaborator INDUSTRY

  • Anne Birgitte Raben

    lead OTHER

Principal Investigators

  • Anne B Raben, prof · University of Copenhagen

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2018-09-10
Primary Completion
2019-03-21
Completion
2019-03-21

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03656367 on ClinicalTrials.gov